IDEXX Laboratories Inc (IX1.BE)
| Previous Close | 473.30 |
| Open | 462.10 |
| Bid | 464.20 x 0 |
| Ask | 468.10 x 0 |
| Day's Range | 462.10 - 462.10 |
| 52 Week Range | 368.00 - 532.00 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day
WESTBROOK, Maine, May 14, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon, Executive Vice President and Chief Financial Officer, and Michael Lane, Executive Vice President, General Manager, Reference Laboratories and Information Technology, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 29, 2024 from 10:55 am – 11:25 am (EDT).
- Business Wire
IDEXX Laboratories Announces First Quarter Results
WESTBROOK, Maine, May 01, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results.
- Business Wire
IDEXX Laboratories to Release 2024 First Quarter Financial Results
WESTBROOK, Maine, April 04, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
